Parmax Pharma Q2 Results
- BSE: 540359
- NSE: -
- ISIN: INE240T01014
- Sector: Biotechnology & Drugs
BSE
43.7
0.00 (0.00%)
0.00 (0.00%)Volume7.00
Updated: Tue 26 Nov, 2024 | 10:56:21
NSE
This stock is not traded on NSE
Technical Trends
Long TermConsiders price movement over the last 6 months
Not Available
Short TermConsiders price movement over the last 1-2 weeks
Not Available
- Bearish
- Moderately Bearish
- Neutral
- Moderately Bullish
- Bullish
Insight: Trends unavailable at the moment.
Q2 Results Highlights
Note: Comparison is on QoQ basis
Quarterly - Parmax Pharma Q2 Results
*All figures in crores except per share values
| Fiscal Period | Sep 23 | Jun 23 | QoQ Comp |
|---|---|---|---|
| Total Revenue | 4.07 | 1.40 | -% |
| Selling/ General/ Admin Expenses Total | 0.85 | 0.72 | -% |
| Depreciation/ Amortization | 0.43 | 0.42 | -% |
| Other Operating Expenses Total | 1.25 | 0.90 | -% |
| Total Operating Expense | 5.26 | 2.47 | -% |
| Operating Income | -1.20 | -1.07 | -% |
| Net Income Before Taxes | -1.37 | -1.18 | -% |
| Net Income | -1.37 | -1.18 | -% |
| Diluted Normalized EPS | -3.66 | -3.15 | -% |
EQUITY QUICK LINKS
FROM MARKETS
Trending Stocks
- Markets
01NTPC Green Energy IPO allotment status out. GMP, how to check status online
2 min read06:38 AM IST - Markets
02Enviro Infra Engineers IPO day 2: GMP jumps; subscription status, review, apply or not?
3 min read25 Nov 2024 - Markets
03C2C Advanced Systems IPO Day 2: Check GMP, subscription status and other key details
2 min read25 Nov 2024